Abstract:Background: Gastro-oesophageal reflux has been suggested to play a role in eosinophilic oesophagitis (EoO). Oesophageal acid exposure decreases baseline intraluminal impedance, a marker of mucosal integrity, in patients with gastro-oesophageal reflux disease (GORD). Objectives: The aim of this study was to assess oesophageal baseline impedance levels in EoO patients and to investigate their relationship with oesophageal acid exposure. Methods: Ambulatory 24-h pH-impedance monitoring was performed in 11 EoO pat… Show more
“…In that study, we observed that in patients with PPI-REE histological response to PPI treatment was associated with improvement of the esophageal mucosal barrier integrity. In EoE patients, PPIs do not aff ect esophageal mucosal integrity, which perhaps is not surprising because by defi nition those who respond to PPIs are not diagnosed with EoE ( 10,23 ). However, similar to the eff ect of PPIs in patients with PPI-REE, we now found that improvement of the esophageal mucosal barrier integrity in response to fl uticasone propionate treatment paralleled the decrease of esophageal infl ammation.…”
Fluticasone propionate treatment decreases eosinophilic inflammation and improves the esophageal mucosal barrier integrity in adult EoE patients. Improvement of the mucosal barrier integrity correlates with normalization of expression of desmoglein-1 and filaggrin marker genes.
“…In that study, we observed that in patients with PPI-REE histological response to PPI treatment was associated with improvement of the esophageal mucosal barrier integrity. In EoE patients, PPIs do not aff ect esophageal mucosal integrity, which perhaps is not surprising because by defi nition those who respond to PPIs are not diagnosed with EoE ( 10,23 ). However, similar to the eff ect of PPIs in patients with PPI-REE, we now found that improvement of the esophageal mucosal barrier integrity in response to fl uticasone propionate treatment paralleled the decrease of esophageal infl ammation.…”
Fluticasone propionate treatment decreases eosinophilic inflammation and improves the esophageal mucosal barrier integrity in adult EoE patients. Improvement of the mucosal barrier integrity correlates with normalization of expression of desmoglein-1 and filaggrin marker genes.
“…Several mechanisms have been suggested as an explanation for the considerable response to PPI. This suggests that acid reflux may play a potentiating role in the increased permeability of the esophageal mucosa, facilitating transepithelial allergen flux in PPI-REE [23]. Esophageal eosinophil infiltration in EoE may be because of acid reflux as it has been shown that acid exposure can contribute toward an increased esophageal permeability because of mucosal damage [22].…”
Endoscopic signs at baseline endoscopy cannot distinguish EoE from PPI-REE before a PPI trial; the demographic and clinical characteristics in both groups are similar. Endoscopic features do not enable differentiation between PPI-REE and EoE.
“…Baseline impedance values were markedly lower in EoE patients along the entire length of the oesophagus, not only in distal oesophagus, when compared to matched healthy controls [50]. Of note, impedance values in EoE did not correlate with acid exposure or the number or reflux episodes [50].…”
Section: A C C E P T E D Accepted Manuscriptmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.